Sharepoint Solutions
PRODUCTS
-
CAI’s Kneat: Data Ready provides you with best-in-class content and templates created by industry-leaders, giving you a headstart in implementing your own Kneat solution.
Kneat: Data Ready offers not only templates, but a validated out-of-the-box configuration that you can tailor to your business needs. Implement your Kneat instance in less than half the time.
-
Finding a partner with integrated services is crucial for accelerating timelines and accessing solutions with comprehensive expertise, all while removing risk from the drug product lifecycle.
-
With AES pre-engineered modular construction, our clients are leveraging our clean construction techniques to ensure that the project site starts clean and stays clean throughout the construction of the facility.
-
DispenCell Single-Cell Dispenser
A simple single-cell dispenser for proof of monoclonality
The DispenCell™ Single-Cell Dispenser is an automated laboratory instrument designed for fast, easy, and gentle single-cell isolation. DispenCell integrates seamlessly into your laboratory workflow, with a plug-and-play approach.
-
Kneat enables regulated companies to consolidate validation and quality management into a single end-to-end web-based software platform.
CAI’s Kneat: Project-Ready allows your company to utilize a validated Kneat instance to execute your projects without start-up and on-going maintenance. Project-Ready does the heavy lifting for you with pre-designed processes and templates.
WHITE PAPERS AND CASE STUDIES
-
Biostatistics And Programming — More Than Just Clinical Trials
See how our biostatisticians and programmers successfully ingested, cleaned, and analyzed the data, ultimately providing a small biotech company with several interesting and actionable measures.
-
IT Changes Implemented To Overcome Future Manufacturing Challenges
Learn how Pfizer and Ferring improved their reporting and batch information management with Rockwell’s technology.
-
Success Factors For Launching Products With Orphan Drug Designation
Orphan drug designation offers a number of financial incentives to pharmaceutical companies. Learn more about the potential hurdles of orphan drug development and the opportunities to maximize your success.
-
Top-Tier University Stays Compliant With HRPP Assessment
Discover how one university was able to identify and resolve programmatic gaps in compliance with federal regulations and revitalize its Human Research Protection Program.
-
Choose How You Want To Pay: Flexibility In The Payment Process
As the payment method landscape continues to evolve, retailers should have a strategy that takes into account current preferences and – to the extent possible – anticipates future changes.
-
The Impact Of Artificial Intelligence On CQV
AI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
A Digital Solution Embeds Quality Into Cellular Therapeutics Production
Discover how Dendreon cut review and release time by nearly 50% while maintaining a 99% right-first-time rate, which boosts collaboration, visibility, and operational efficiency across teams.
-
Advancing In Silico Predictions In Early Drug Discovery
Examine a high-throughput approach that streamlines LogD measurements, offering faster and more accurate insight into compound lipophilicity to support better decision-making in early drug discovery.
-
Performance Of Protein A Resins For Different mAbs
Review a Protein A resin solution assisting biotech companies who are working with and removing impurities from a wide variety of antibodies.
-
Reducing Risk And Timelines In Cell Line Development
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
Navigating The Translation To Clinic: Future-Proof Your Plasmid Products
Future-proofing products with strategies that reduce risk and timelines for later stages can be resource-intensive but add significant value. Explore the challenges encountered progressing from development to clinic.
-
Applying A Platform Approach To Bispecific Antibody Development
Explore how experts were able to adjust a mAb production and purification platform to be applicable for the rapid development and scale up of a BsAb.
NEWS
-
Biden-Harris Administration Announces $7.5B In Available Financing For Water Infrastructure Projects9/6/2024
Today, September 6, the U.S. Environmental Protection Agency announced the availability of $7.5B of Water Infrastructure Finance and Innovation Act (WIFIA) funding.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research2/6/2025
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.
-
EPA Announces $194M To King County To Improve Wastewater Infrastructure Resiliency, Protect Puget Sound3/28/2024
Today, at an event at the West Point Treatment Plant, the U.S. Environmental Protection Agency Acting Assistant Administrator for Water Bruno Pigott announced a $194M Water Infrastructure Finance and Innovation Act loan to King County in Washington.
-
EGLE Announces $27.1M In MI Clean Water Grants To Help Michigan Communities Upgrade Water Infrastructure, Protect Health, Environment7/12/2024
Sanitary and storm sewer upgrades in Escanaba, a new drinking water well in Haring Township, and investigations of lead service line locations in eight communities are among $27.1M in state grants recently awarded to Michigan cities, villages, and townships to protect public health and Michigan’s water resources.
-
New Antibiotic Class Effective Against Multidrug-Resistant Bacteria4/1/2024
Scientists at Uppsala University have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice. The new antibiotic class is described in an article in the scientific journal PNAS.